Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study Yingying ShenQi LiuDijiong Wu Original Article Open access 09 January 2023 Pages: 503 - 517
Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients Mehrnaz AhmadiSamira BeiranvandCamelia Rohani Original Article Open access 04 November 2022 Pages: 519 - 528
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine Lele ZhangJin MaoJun Shi Original Article 21 January 2023 Pages: 529 - 539
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia Masayuki AibaAkio ShigematsuTakuto Miyagishima Original Article Open access 16 January 2023 Pages: 541 - 546
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study Dietger NiederwieserThomas LangVerena S. Hoffmann Original Article Open access 25 January 2023 Pages: 547 - 561
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course Fanny DelehayeJérémie RougerFrédéric Millot Original Article 12 November 2022 Pages: 563 - 570
Real-world treatments and thrombotic events in polycythemia vera patients in the USA Srdan VerstovsekNaveen PemmarajuSuneel Gupta Original Article Open access 13 January 2023 Pages: 571 - 581
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis Shihui MaoYu QianJie Jin Original Article 26 January 2023 Pages: 583 - 595
Venetoclax-based combination therapy in R/R DLBCL patients with failure of CAR-T therapy Ying ZhuSicheng AiHaiwen Huang Original Article 30 January 2023 Pages: 597 - 601
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers Benedikt FrankGabriele IhorstMonika Engelhardt Original Article Open access 05 December 2022 Pages: 603 - 611
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis Joseph CioccioKevin RakszawskiHiroko Shike Original Article 17 December 2022 Pages: 613 - 620
Autologous stem cell transplantation in multiple myeloma patients with renal impairment Yingying ZhaiLingzhi YanDepei Wu Original Article 12 January 2023 Pages: 621 - 628
Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation Woochan ParkJa Min ByunSung-Soo Yoon Original Article Open access 20 January 2023 Pages: 629 - 639
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA) Nicole C. van YperenBianca WaubenHarry C. Schouten Original Article 31 December 2022 Pages: 641 - 649
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation Kimimori KamijoYoshimitsu ShimomuraEisei Kondo Original Article Open access 12 January 2023 Pages: 651 - 661
Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies? Aryanna JordanAkriti G. JainMichael Jaglal Original Article 19 December 2022 Pages: 663 - 668
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia Martin StanullaDenis M. ScheweBritta Maecker-Kolhoff Letter to the Editor Open access 18 January 2023 Pages: 669 - 672
Thyrotoxicosis after unrelated cord blood transplantation for adults Takaaki KonumaAkira TomonariSatoshi Takahashi Letter to the Editor 17 December 2022 Pages: 673 - 676
GP1BB c.179C > T is the most frequent cause of monoallelic Bernard–Soulier syndrome in the Italian population after the Bolzano variant: a report of two new families Serena BarozziAlessandro PecciMichela Faleschini Letter to the Editor 21 December 2022 Pages: 677 - 679
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia Alessandro CelliniFederico ScarmozzinoAndrea Visentin Letter to the Editor 21 December 2022 Pages: 681 - 682
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy Kelly J. GaffneyMary McGannHamza Hashmi Letter to the Editor 19 January 2023 Pages: 683 - 685
Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant Carly WujekRotem Fishel Ben-KenanKeith A. Sacco Letter to the Editor 17 December 2022 Pages: 687 - 688
